Contact us

Browse by products

Featured content

  • Bacteria & Viruses related products
    Abinscience provides high-quality tools for studying viruses, superbugs, and parasites, including monkeypox, Ebola, and other emerging pathogens, supporting diagnostics, vaccine development, and therapeutic discovery.
    Learn more
  • Neuroscience
    Abinscience provides tools for studying Alzheimer's, Parkinson's, and Huntington's disease, supporting biomarkers, diagnostics, and therapy development in neuroscience.
    Learn more
  • Therapeutic Targets
    Abinscience provides tools for studying therapeutic targets, including CD3E, CTLA4, PD1, PDL1, B7-H3, CEA, CD200R1, SIRPA, and CCR8, supporting biomarkers, diagnostics, and therapy development.
    Learn more
  • DNA/RNA Research Antibodies
    Abinscience offers anti-dsRNA antibodies (J2, K1, K2), widely recognized in virology, immunology, and RNA research for their exceptional specificity and sensitivity, empowering scientists to explore the RNA world
    Learn more
  • Biotoxin Antibodies
    Reliable antibodies for botulinum, ricin, tetanus, and other toxins, enabling sensitive detection and toxin research.
    Learn more
  • Autoimmune Diseases
    High-specificity antibodies and ELISA kits for key targets like TNF-α, IL-6, IFN-γ, PD-1, and CTLA-4, enabling reliable cytokine detection and immune regulation studies.
    Learn more
  • MHC Complex
    Specific antibodies for MHC I, MHC II, and related molecules, supporting antigen presentation, immune response, and disease research.
    Learn more
  • TACAs Antibodies
    Targeting tumor-associated carbohydrate antigens (Tn, STn, MUC1, CA15-3, CA72-4) to support cancer immunotherapy and biomarker research
    Learn more
  • Model Organism
    Learn more

    • About Abinscience

    News

  • High-Quality TSHR Recombinant Proteins and Antibodies for Thyroid Research
    Explore high-quality TSHR recombinant proteins and antibodies from Abinscience, designed for thyroid research, Graves' disease studies, and diagnostic applications.
    Learn more
  • Advance Phage Display Research with Abinscience M13 Monoclonal Antibody
    Discover how Abinscience's high-affinity, highly specific M13 monoclonal antibody enhances phage display efficiency, specificity, and reliability across ELISA, flow cytometry, and Western blot applications.
    Learn more
  • Measles Virus Unveiled: Resurgence, Hidden Potential, and Research Tools
    On February 26, 2025, a measles outbreak in Texas, marked by the first U.S. death since 2015, underscores declining vaccination rates (82% in Gaines County vs. 93% nationally) and its spread to over 124 cases. Beyond this public health challenge, the measles virus (MeV) shows promise in oncolytic virotherapy, targeting tumors via receptors like CD46 and nectin-4, inducing immune responses, and undergoing genetic engineering for cancers such as glioblastoma and multiple myeloma. Abinscience offers recombinant MeV proteins to advance research into its biology and therapeutic potential, bridging virology and oncology.
    Learn more
  • Biosimilars of Monoclonal Antibodies: A Powerful Tool for Advancing Cancer Research
    Explore the role of biosimilars of monoclonal antibodies in advancing cancer research. This article delves into how biosimilars are transforming drug development and providing essential tools for oncologists and researchers, enhancing the accessibility and effectiveness of biologic therapies in cancer treatment.
    Learn more
  • A New Bat-Originated Virus with Potential Human Infection Risk – HKU5-CoV-2
    On February 18, 2025, researchers at the Wuhan Institute of Virology published groundbreaking findings in Cell journal, revealing a newly discovered bat-origin coronavirus, HKU5-CoV-2. This discovery highlights a potential new viral threat with distinctive infection mechanisms and a risk of cross-species transmission. While the study emphasizes that the virus has characteristics limiting its ability to spread among humans, the possibility of cross-species transmission remains concerning.
    Learn more
  • Apolipoprotein E4 and Alzheimer’s Disease: Pathogenic Mechanisms, Therapeutic Strategies, and Molecular Insights
    ApoE4 is a major genetic risk factor for Alzheimer’s disease (AD), contributing to lipid metabolism dysfunction, neuroinflammation, and Aβ aggregation. This article explores ApoE4’s role in AD pathology and highlights therapeutic strategies, including gene editing, immunotherapy, structural correctors, and lipidation enhancement. Targeting ApoE4 offers promising avenues for AD treatment and neuroprotection.
    Learn more
  • IL-17A in Immune Regulation: Mechanisms and Advanced Reagents
    This article examines IL-17A's critical role in immune regulation and inflammation, detailing its structure, signaling pathways, and cellular sources. It also highlights advanced IL-17A reagents from Abinscience, empowering cutting-edge research in autoimmune and inflammatory diseases.
    Learn more
  • Semaglutide Leading the Next Generation of Obesity and Chronic Disease Treatment: Latest Clinical Advances and High-Quality Research Support
    Semaglutide, a potent GLP-1 receptor agonist, has demonstrated remarkable efficacy in managing obesity, type 2 diabetes, and associated chronic conditions. Its rising global sales underscore its effectiveness in promoting weight loss and glycemic control, while emerging evidence highlights its potential benefits for inflammatory diseases like knee osteoarthritis. As indications expand, high-quality reagents and technical support are crucial for advancing Semaglutide research. Abinscience offers specialized ELISA kits and antibody products that empower scientists to explore the drug’s mechanisms and accelerate progress in obesity and metabolic disease therapies worldwide
    Learn more
  • Unlock the Power of dsRNA Detection with Abinscience’s Anti-dsRNA Antibodies
    Abinscience’s anti-dsRNA antibodies (J2, K1, K2) are industry-leading tools for detecting double-stranded RNA (dsRNA) with high specificity and sensitivity. Widely used in virology, mRNA vaccine development, and immune pathway research, these antibodies ensure precise dsRNA detection, supporting viral studies, quality control, and immunotherapy advancements.
    Learn more
  • CD77: Structure, Function, Clinical Relevance, and Flow Cytometry Applications
    Explore the structure, function, and clinical significance of CD77, a key glycosphingolipid involved in Burkitt lymphoma, Shiga toxin interaction, and targeted cancer therapy. Learn about its applications in flow cytometry and biomedical research with high-quality CD77 antibodies and reagents.
    Learn more
  • Exploring Innovations in Bispecific Antibodies for Immunotherapy
    Bispecific antibodies (BsAbs) are revolutionizing cancer and immunotherapy, with Merck & Co. investing $1.3 billion in CD19/CD3 BsAb CN201. Learn how BsAbs enhance immune activation and tumor elimination.
    Learn more
  • Influenza, RSV: Key Proteins, Antibodies, and Research Solutions
    Influenza and RSV cause seasonal outbreaks, posing risks to infants and the elderly. Key proteins like Hemagglutinin (HA), Neuraminidase (NA), and RSV Fusion Glycoprotein (F) are vital for vaccine and antiviral research. Abinscience offers recombinant proteins, antibodies, and ELISA kits to advance virology studies in diagnostics and therapeutics.
    Learn more

    • Quick access

    Contact us

    • +33(0)3 90 20 54 70

    • info@abinscience.com

    • 19 rue de la Haye 67300 Schiltigheim France

    Copyright © 2025 Abinscience. All Rights Reserved. All Products are for Research Use Only